The clinical potential of blood-proteomics in multiple sclerosis

The clinical potential of blood-proteomics in multiple sclerosis

Bibliographic Details
Main Authors:	De Masi, Roberto, Pasca, Sergio, Scarpello, Rocco, Idolo, Adele, De Donno, Antonella
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674984/

Similar Items

Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption
by: De Masi, Roberto, et al.
Published: (2015)

Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration
by: Liguori, Maria, et al.
Published: (2014)

Nutrition Facts in Multiple Sclerosis
by: Riccio, Paolo, et al.
Published: (2015)

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
by: Avsar, Timucin, et al.
Published: (2015)

Micronuclei in Exfoliated Buccal Cells of Children Living in a Cluster Area of Salento (Southern Italy) with a High Incidence of Lung Cancer: The IMP.AIR Study
by: Adele Idolo, et al.
Published: (2018-08-01)

The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study
by: Nielsen, Helle H., et al.
Published: (2015)

Impact of Stinging Jellyfish Proliferations along South Italian Coasts: Human Health Hazards, Treatment and Social Costs
by: De Donno, Antonella, et al.
Published: (2014)

Multiple sclerosis - New treatment modalities
by: Totaro, Rocco, et al.
Published: (2015)

Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
by: Elyaman, Wassim, et al.
Published: (2011)

The Refinement of Genetic Predictors of Multiple Sclerosis
by: Disanto, Giulio, et al.
Published: (2014)

In-Depth Profiling of the Peripheral Blood Mononuclear Cells Proteome for Clinical Blood Proteomics
by: Končarević, Saša, et al.
Published: (2014)

Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications
by: Dudani, Sharmila J, et al.
Published: (2011)

Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
by: Füvesi, Judit, et al.
Published: (2012)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
by: Liu, Shilian, et al.
Published: (2009)

Multiple Sclerosis and the Blood-Central Nervous System Barrier
by: Palmer, Alan M.
Published: (2013)

Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
by: Tejera-Alhambra, Marta, et al.
Published: (2015)

Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System
by: Kern, Raimar, et al.
Published: (2016)

Editorial: Fatigue in Multiple Sclerosis
by: Dettmers, Christian, et al.
Published: (2015)

Pregnancy in multiple sclerosis: clinical and self-report scales
by: Neuteboom, R. F., et al.
Published: (2011)

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
by: PAVELEK, ZBYŠEK, et al.
Published: (2016)

Tremor in multiple sclerosis
by: Koch, Marcus, et al.
Published: (2007)

Clinical and imaging approach to headache in patients with multiple sclerosis
by: Voiticovschi-Iosob, C, et al.
Published: (2013)

Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study
by: Ramsaransing, Geeta SM, et al.
Published: (2009)

Clinical correlates of grey matter pathology in multiple sclerosis
by: Horakova, Dana, et al.
Published: (2012)

The Role of Neurotrophins in Multiple Sclerosis—Pathological and Clinical Implications
by: Kalinowska-Lyszczarz, Alicja, et al.
Published: (2012)

How to run a multiple sclerosis relapse clinic
by: Tallantyre, Emma C, et al.
Published: (2016)

Optic Neuritis as First Clinical Manifestations the Multiple Sclerosis
by: Halilovic, Emina Alimanovic, et al.
Published: (2014)

Defining the clinical course of multiple sclerosis: The 2013 revisions
by: Lublin, Fred D., et al.
Published: (2014)

Clinical Implications of Neuroplasticity – The Role of Rehabilitation in Multiple Sclerosis
by: Flachenecker, Peter
Published: (2015)

The importance of collecting structured clinical information on multiple sclerosis
by: Ziemssen, Tjalf, et al.
Published: (2016)

The challenge of comorbidity in clinical trials for multiple sclerosis
by: Marrie, Ruth Ann, et al.
Published: (2016)

Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis
by: Fiorini, Ada, et al.
Published: (2013)

Multiple Sclerosis
by: Gaby, Alan
Published: (2013)

Multiple Sclerosis
by: Ramagopalan, Sreeram, et al.
Published: (2011)

MULTIPLE SCLEROSIS
by: Ivan M., Sharman
Published: (1987)

Microvesicles: What is the Role in Multiple Sclerosis?
by: Carandini, Tiziana, et al.
Published: (2015)

Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients
by: Grima, Pierfrancesco, et al.
Published: (2011)

Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
by: Lee, De-Hyung, et al.
Published: (2013)

Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study
by: Conte, Antonella, et al.
Published: (2015)

MicroRNA dysregulation in multiple sclerosis
by: Jr, Omar de Faria, et al.
Published: (2013)